MRPL38 Antibody

MRPL38 Protein Characteristics and Detection

MRPL38, or mitochondrial ribosomal protein L38, is a protein with a calculated molecular weight of 346 amino acids and approximately 41 kDa. In laboratory settings, the observed molecular weight typically falls within the 37-45 kDa range, which is consistent across multiple antibody validation studies . This protein is encoded by the MRPL38 gene (NCBI Gene ID: 64978) and has been assigned the UniProt ID Q96DV4 . Understanding these basic characteristics is essential for proper experimental design and interpretation of results when working with MRPL38 antibodies.

Species Reactivity Profiles

A critical consideration when selecting MRPL38 antibodies is their species reactivity profile. Different commercial antibodies demonstrate varying reactivity patterns that must be matched to experimental needs:

For cross-species studies, the polyclonal antibody 15913-1-AP offers broader reactivity across human, mouse, and rat samples, making it suitable for comparative studies . In contrast, the monoclonal antibody 68418-1-Ig has confirmed reactivity with human and pig samples, potentially offering higher specificity for these species . Researchers should validate the specific reactivity in their model systems before proceeding with extensive experimentation.

Standard Applications and Recommended Dilutions

MRPL38 antibodies can be utilized across multiple experimental applications with specific dilution requirements for optimal results:

These dilution ranges represent starting points, and researchers should optimize conditions for their specific experimental systems . Titration experiments are recommended to determine the optimal antibody concentration that provides maximum signal-to-noise ratio for each experimental condition.

Polyclonal versus Monoclonal MRPL38 Antibodies

The choice between polyclonal and monoclonal MRPL38 antibodies depends on experimental requirements and research goals:

Polyclonal antibodies (e.g., 15913-1-AP) offer:

• Recognition of multiple epitopes, increasing detection sensitivity

• Broader species cross-reactivity (human, mouse, rat)

• Effective for Western blot, IHC, and flow cytometry applications

• Antigen affinity purification methodology

Monoclonal antibodies (e.g., 68418-1-Ig) provide:

• Recognition of a single epitope, enhancing specificity

• Higher concentration working dilutions (1:2000-1:10000 for WB)

• Protein G purification methodology

• Consistency between lots due to clonal production

For experiments requiring highest specificity, such as distinguishing between closely related proteins, monoclonal antibodies generally provide superior performance. Conversely, when maximum sensitivity is needed, particularly in samples with low MRPL38 expression, polyclonal antibodies may be preferable.

Tissue-Specific Detection Optimization

MRPL38 expression varies across tissues, necessitating protocol adaptations for optimal detection:

For immunohistochemistry applications using the 15913-1-AP antibody, antigen retrieval optimization is critical. The recommended protocol suggests using TE buffer at pH 9.0, with an alternative option of citrate buffer at pH 6.0 if results are suboptimal . This antigen retrieval step is essential for exposing epitopes that may be masked during fixation processes, particularly in formalin-fixed, paraffin-embedded tissues.

Advanced Protocol Considerations for Western Blot

When conducting Western blot analyses with MRPL38 antibodies, several technical considerations can enhance detection quality:

• Sample preparation: Mitochondrial enrichment protocols may increase detection sensitivity for MRPL38, given its localization to mitochondrial ribosomes.

• Blocking optimization: For polyclonal antibody 15913-1-AP, a typical blocking procedure with 5% non-fat milk in TBST is recommended, while for monoclonal antibody 68418-1-Ig, researchers may need to evaluate whether BSA-based blocking solutions reduce background.

• Incubation conditions: Primary antibody incubations are typically performed overnight at 4°C, but application-specific protocols provided by manufacturers should be followed for optimal results .

• Detection systems: Enhanced chemiluminescence (ECL) systems are compatible with both antibodies, though sensitivity requirements may dictate selection of standard versus highly sensitive detection reagents.

MRPL38 Antibodies in Mitochondrial Research

MRPL38 antibodies serve as valuable tools in mitochondrial research, particularly for studying:

• Mitochondrial ribosome assembly and function: As a component of the large subunit of mitochondrial ribosomes, MRPL38 antibodies can be used to investigate mitochondrial translation processes.

• Mitochondrial disease models: Alterations in mitochondrial ribosomal proteins have been implicated in various pathological conditions, making MRPL38 antibodies useful for examining protein expression changes in disease states.

• Co-immunoprecipitation studies: The monoclonal antibody 68418-1-Ig has been validated for immunoprecipitation applications, enabling investigation of MRPL38 protein-protein interactions within the mitochondrial translation machinery .

Researchers investigating mitochondrial functions should consider using MRPL38 antibodies in conjunction with other mitochondrial markers to provide comprehensive analysis of mitochondrial processes.

Antibody Specificity Verification

Ensuring antibody specificity is fundamental to generating reliable research results. For MRPL38 antibodies, several validation approaches are recommended:

• Positive control selection: Use validated positive samples such as mouse brain tissue for 15913-1-AP or A549 cells for 68418-1-Ig .

• Molecular weight verification: Confirm that detected bands fall within the expected 37-45 kDa range, as consistently observed in validation studies .

• Knockout/knockdown controls: Where available, MRPL38 knockdown or knockout samples provide the most stringent specificity control.

• Cross-reactivity assessment: Particularly when using polyclonal antibodies, evaluate potential cross-reactivity with other mitochondrial ribosomal proteins of similar molecular weight.

These validation steps should be performed when establishing a new experimental system or when using a new lot of antibody.

Troubleshooting Non-specific Signals

When encountering non-specific signals with MRPL38 antibodies, systematic troubleshooting approaches include:

• Antibody dilution optimization: Increasing dilution may reduce non-specific binding, particularly for polyclonal antibodies.

• Blocking protocol adjustment: Extended blocking times or alternative blocking agents may reduce background.

• Wash stringency modifications: Increasing wash duration or detergent concentration can help eliminate non-specific binding.

• Secondary antibody evaluation: Testing alternative secondary antibodies or increasing their dilution may reduce non-specific signals.

Each of these parameters should be systematically evaluated while maintaining positive control detection to optimize signal-to-noise ratio.

MRPL38 in Gene Expression Profiling

Recent research has identified MRPL38 as part of gene signatures in autoimmunity studies. In the context of rheumatoid arthritis research, gene expression profiling has revealed distinctive patterns in autoantibody-positive individuals at risk for developing the disease . Though not specifically focused on MRPL38, these approaches demonstrate how antibody-based validation can complement transcriptomic analyses to understand protein expression patterns in disease states.

Multiparametric Analysis Incorporating MRPL38

For comprehensive cellular analyses, MRPL38 antibodies can be incorporated into multiparametric studies:

• Flow cytometry panels: The validated intracellular staining protocol for 15913-1-AP (0.50 μg per 10^6 cells) enables inclusion of MRPL38 in flow cytometry panels examining mitochondrial markers .

• Multiplex immunofluorescence: Combined staining with other mitochondrial proteins can provide spatial information about MRPL38 localization relative to mitochondrial subcompartments.

• Co-localization studies: Paired analysis with nucleoid markers or other mitochondrial ribosomal proteins can reveal functional associations within mitochondrial translation complexes.

These approaches extend beyond basic detection to address mechanistic questions about MRPL38 function within cellular contexts.

Optimal Storage Conditions

To maintain antibody performance over time, proper storage is essential:

• Temperature: Both 15913-1-AP and 68418-1-Ig should be stored at -20°C for long-term stability .

• Buffer composition: These antibodies are supplied in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3, which helps maintain stability during freeze-thaw cycles .

• Aliquoting considerations: For the standard sizes, manufacturers indicate that aliquoting is unnecessary for -20°C storage, simplifying laboratory handling procedures .

• Stability parameters: When properly stored, these antibodies are reported to be stable for one year after shipment, providing a reasonable working timeframe for research projects .

Adherence to these storage recommendations ensures consistent antibody performance throughout experimental timeframes.

Working Solution Preparation

When preparing working solutions of MRPL38 antibodies:

• Thawing procedure: Allow antibodies to thaw completely at room temperature before use.

• Dilution buffer selection: For Western blot applications, dilute antibodies in the same buffer used for blocking (typically TBST with 5% non-fat milk or BSA).

• Handling precautions: Minimize freeze-thaw cycles, and avoid contamination by using sterile technique when accessing antibody stock solutions.

• Working solution storage: Diluted antibody solutions for Western blot can typically be stored at 4°C for up to one week, while dilutions for more sensitive applications like IHC should be prepared fresh.

These handling practices help preserve antibody integrity and experimental reproducibility.